Nucala 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FDL03
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $113,574
Award facts
- Contract value 100% obligated
- $113,574.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $113,574.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/mL syringes. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure consistent contracts with the Defense Logistics Agency. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. Nucala, a biologic medication used to treat eosinophilic conditions, represents the type of specialized pharmaceutical product the contractor regularly supplies to support military medical operations and readiness.
Quick answers
Who was awarded contract SPE2DB25FDL03?
SPE2DB25FDL03 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FDL03 worth?
The government has obligated $113,574 on SPE2DB25FDL03.
Is contract SPE2DB25FDL03 an order under another contract?
Yes. SPE2DB25FDL03 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL03 competed?
The extent of competition for SPE2DB25FDL03 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award